A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
This protocol provides a combination strategy of two herbs to treat injured PC12 cells. The protocol provides a reference for optimizing the best application mode of traditional Chinese medicine (TCM).
In view of the advantages of the combination of traditional Chinese medicine (TCM) in the treatment of cerebral ischemia, we studied the differences in the efficacy and mechanism between the preparation combination and the component combination in order to explore the two herb combination strategy to treat injured PC12 cells. Cobalt chloride (CoCl2) combined with a glucose-free medium was employed to induce oxidative damage of PC12 cells. Then, the optimal combination of Astragalus mongholicus (Ast) and Erigeron breviscapus (Eri) injection was selected and combined following uniform design methods after screening their safe and effective concentration on PC12 cells. Further, the component combination screened comprises 10 µM astragaloside A, 40 µM scutellarin, and 75 µM chlorogenic acid in two herbs. Then, MTT, Annexin V-FITC/PI, immunofluorescence, and Western blot analysis were used to evaluate the efficacy and mechanism of the preparation combination and the component combination on injured PC12 cells. The results showed that the optimal preparation combination for cell pro-survival was Ast injection and Eri capsule with a concentration of 6:1.8 (µM). The component combination (10 µM astragaloside A, 40 µM scutellarin, and 75 µM chlorogenic acid) was more effective than the preparation combination. Both combinations remarkably reduced apoptotic rate, the fluorescence intensity of caspase-3, and intracellular reactive oxygen species (ROS) level; meanwhile, they upregulated the expression levels of p-Akt/Akt, Bcl-2/Bax, and Nrf2. These effects were more evident in the component combination. In conclusion, both combinations can inhibit the injury induced by CoCl2 combined with a glucose-free medium on PC12 cells, thus promoting cell survival. However, the efficiency of the component combination over the preparation combination may be due to its stronger regulation of the PI3K/Akt/Nrf2 signaling pathway related to oxidative stress and apoptosis.
Chronic cerebral ischemia, caused by cerebral hypoperfusion, is a common disease in middle-aged and elderly people1. As a long-term occult ischemia disease, it can lead to progressive or persistent neurological dysfunction. The main pathological mechanisms include cell apoptosis and oxidative damage, leading to progressive or persistent neurological dysfunction; this is the pathological basis of Alzheimer's disease, vascular dementia, and other diseases, and seriously affects the quality of life of patients. However, there is still a lack of ideal drugs in modern medicine to treat chronic cerebral ischemia2. At the same ....
1. Preparation of reagent
The screening of the optimal combination of Ast injection and Eri capsule is shown in Figure 1. The cell survival rate of Ast injection and Eri capsule on the normal PC12 cells is shown in Figure 1A. The cell viability was lower than 95% with Ast injection at concentrations greater than 12 µM (Figure 1A) and Eri capsule at concentrations greater than 5 µM (Figure 1A), indicating that the .......
There is still a lack of ideal drugs for the treatment of cerebral ischemia in modern clinical practice2. Under the guidance of supplementing qi and activating the blood circulation method, Ast, Eri, and other preparations have been used in combination in the clinical practice of TCM and have achieved good comprehensive advantages13,14,15. A large number of studies have shown that Ast can improve the perm.......
This research was funded by Key R & D projects of the Sichuan Provincial Department of science and technology (2020YFS0325).
....Name | Company | Catalog Number | Comments |
1300 series class II biosafety cabinet | Thermo Fisher Scientific Instruments Company | 1374 | |
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide | Guangzhou saiguo biotech Company | 1334GR001 | MTT |
ACEA NovoExpress 1.4.0 | ACEA Biosciences, Inc | - | |
Akt | Wuhan Three Eagles Proteintech Group, Inc | 10176-2-AP | |
Analytical flow cytometry | Thermo Fisher Scientific Instruments Company | 62-2-1810-1027-0 | |
Annexin V-FITC apoptosis detection kit | Beyotime Biotechnology Company | C1062L | |
Astragalus injection | Heilongjiang Zhenbao Island Pharmaceutical Company | A03190612144 | Ast injection |
Astragaloside A | Chongqing Gao Ren Biotechnology Company | 84687-43-4 | |
Bax | Wuhan Three Eagles Proteintech Group, Inc | 60267-1-Ig | |
BCA protein quantification kit | Beyotime Biotechnology Company | P0012 | |
Bcl-2 | Wuhan Three Eagles Proteintech Group, Inc | 26593-1-AP | |
Carbon dioxide incubators | Thermo Fisher Scientific Instruments Company | 0816-2014 | |
Caspase-3 | Wuhan Three Eagles Proteintech Group, Inc | 19677-1-AP | |
Chlorogenic acid | Chongqing Gao Ren Biotechnology Company | 327-97-9 | |
Cobalt chloride hexahydrate | Merck Biotechnology, Inc. | 7791-13-1 | CoCl2 |
Dimethyl sulfoxide | Guangzhou saiguo biotech Company | 2020112701 | DMSO |
Disodium hydrogen phosphate dodecahydrate | Chengdu Kolon Chemical Company | 2020090101 | |
DMEM high sugar medium | Thermo scientific Hyclone | 2110050 | |
DMEM sugar free medium | Beijing Solarbio life sciences Company | 2029548 | |
ECL luminous fluid | Lianshuo Biological Company | WBKLS0500 | |
Electronic balance | Haozhuang Hengping Scientific Instrument Co., Ltd., Shanghai, China | FA1204 | |
Electrophoresis instrument | Bio-Rad Laboratories (Shanghai) Co., Ltd | 1658026 | |
Erigeron breviscapus capsule | Yunnan Biogu Pharmaceutical Company | Z53021671 | Eri capsule |
Fetal bovine serum | Four Seasons Institute of Biological Engineering | 20210402 | FBS |
Fluorescent microscope | Olympms Corporation | IX71-F32PH | |
Gel imager | Bio-Rad Laboratories (Shanghai) Co., Ltd | 1708265 | |
Goat anti-mouse secondary antibody | Wuhan Three Eagles Proteintech Group, Inc | SA00001-1 | |
Goat anti-rabbit secondary antibody | Wuhan Three Eagles Proteintech Group, Inc | SA00001- 2 | |
IBM SPSS Statistics version 26.0 | International Business Machines Corporation, USA | - | |
ImageJ 1.8.0 | National Institutes of Health, USA | - | imaging software |
Immunol fluorescence staining kit | Beyotime Biotechnology Company | P0196 | |
KCl | Chengdu Kolon Chemical Company | 2021070901 | |
Marker | Thermo Fisher Scientific Instruments Company | 26616 | |
Microplate reader | Perkin Elmer Corporate Management (Shanghai) Co. | HH35L2018296 | |
Motic Inverted microscope | Nanda Scientific Instruments Co. | AE2000LED | |
NaCl | Chengdu Kolon Chemical Company | 2014081301 | |
Nonfat milk | Beyotime Biotechnology Company | P0216 | |
Nrf2 | Wuhan Three Eagles Proteintech Group, Inc | 16396-1-AP | |
P-Akt | Wuhan Three Eagles Proteintech Group, Inc | 66444-1-Ig | |
PC12 cells | Chinese Academy of Sciences | CBP60430 | |
Penicillin-Streptomycin solution | Thermo scientific Hyclone | SV30010 | |
Phosphatase protease inhibitor mixture | Beyotime Biotechnology Company | P1045 | |
Potassium dihydrogen phosphate | Chengdu Kolon Chemical Company | 2015082901 | |
Reactive oxygen species assay kit | Beyotime Biotechnology Company | S0033S | |
RI-PA lysis solution | Beyotime Biotechnology Company | P0013B | |
Scutellarin | Chongqing Gao Ren Biotechnology Company | 27740-01-8 | |
SDS-PAGE sample loading buffer, 5x | Beyotime Biotechnology Company | P0015L | |
Sterile filter tips (0.22 µm) | Merck Biotechnology, Inc. | SLGP033RB | |
Tris-base | Guangzhou saiguo biotech Company | 1115GR500 | TBS |
Trypsin | Thermo scientific Hyclone | J190013 | |
Tween-20 | Chengdu Kolon Chemical Company | 2021051301 | |
Vortex oscillator | OHAUS International Co., Ltd., Shanghai, China | VXMNAL | |
β-actin | Wuhan Three Eagles Proteintech Group, Inc | 66009-1-Ig |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved